Investor · CAMBRIDGE, MA

Mark Pruzanski

Open Mark in the network graph →

Filings

10

SEC Form D

Connections

81

co-filers

Capital

$150.4M

across filings

Active

Mar 2021

to Feb 2024

Most-connected co-filers (81)

John L. Walecka · Menlo Park, CA4 shared Dana Witkin · PARK CITY, UT4 shared Henry P. O'Connor · Chevy Chase, MD4 shared David Shapiro · New York, NY2 shared Franklin J. Trotter · Hampton, NH2 shared Nicole Williams · New York, NY2 shared Paul Sekhri · Ann Arbor, MI2 shared Paolo Fundaro · Gainesville, FL2 shared Kathleen Fanning · Seattle, WA2 shared Ezra Friedberg · BRISBANE, CA2 shared James J. Bennett · Hampton, NH2 shared Andrew J. Garman · Hampton, NH2 shared David R. Gust · Oxford, CT2 shared Barbara Duncan · New York, NY2 shared Gino M. Pereira · Oxford, CT2 shared Albert L. Wiegman · CAMBRIDGE, MA2 shared Jonathan T. Silverstein · New York, NY2 shared Sarah Schlesinger · CAMBRIDGE, MA2 shared Steven Gillis · Lexington, MA2 shared Lucio Iannone · Branford, CT2 shared Michael Curtis · Saint-Eustache, Quebec, Canada2 shared Julie Sunderland · Seattle, WA2 shared John J. Wallace · Hampton, NH2 shared Luciano Adorini · New York, NY2 shared

Recent filings (10)

Abcuro, Inc.Feb 2025 · 15 co-filers$200.0M Abcuro, Inc.Feb 2025 · 15 co-filers$200.0M eGenesis, Inc.Feb 2024 · 23 co-filers$28.7M eGenesis, Inc.Feb 2024 · 23 co-filers$28.7M eGenesis, Inc.Mar 2021 · 28 co-filers$125.0M eGenesis, Inc.Mar 2021 · 28 co-filers$125.0M Evelo Biosciences, Inc.Jan 2017 · 23 co-filers$30.5M Evelo Biosciences, Inc.Jan 2017 · 23 co-filers$30.5M Multiplier Capital, LPJul 2014 · 8 co-filers$76.9M Multiplier Capital, LPJun 2013 · 8 co-filers$75.0M Multiplier Capital, LPNov 2012 · 8 co-filers$75.0M INTERCEPT PHARMACEUTICALS INCSep 2012 · 16 co-filers$50.0M INTERCEPT PHARMACEUTICALS INCAug 2012 · 17 co-filers$30.0M Multiplier Capital, LPMay 2012 · 7 co-filers$75.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Mark in the interactive graph →